Fig. 3.

Synergistic treatment of paclitaxel (PTX) and rosiglitazone (RGZ) on the cell cycle of SKOV-3 ovarian cancer cells. (a) Cell cycle distribution. (b) Percent alteration in the cell cycle in control and combination treatment of PTX and RGZ groups. Error bars represent the mean ± SEM of three independent experiments. ns = non-significant, **p < 0.01 and ***< 0.001 as compared to that of the control. ns1  non-significant as compared to that of PTX alone. ns2 non-significant, ^@@@p < 0.001 as compared to that of RGZ alone.